MHE Staff

The novel coronavirus crisis has abruptly upended the operations and behaviors of both businesses and consumers—with such changes seemingly just the beginning.

Despite facing challenges such as limited access to personal protective equipment (PPE) following the COVID-19 outbreak, radiation oncology clinics quickly implemented safety and process enhancements that allowed them to continue caring for cancer patients.

As the coronavirus pandemic swept the U.S., state governments mandated dental offices open only for emergency procedures. But in the coming weeks, some dental practices may resume regular appointments in individual states where businesses considered “essential” are allowed to re-open.

FDA today approved Tecentriq (atezolizumab) as an initial treatment for adults with metastatic non-small cell lung cancer (NSCLC) for certain patients with high programmed-death ligand-1 (PD-L1) expression, marking the fifth approval of the immunotherapy in lung cancer and the fourth in advanced NSCLC.